These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9874819)

  • 1. Experimental determination of dosimetry functions of Ir-192 sources.
    Anctil JC; Clark BG; Arsenault CJ
    Med Phys; 1998 Dec; 25(12):2279-87. PubMed ID: 9874819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo and TLD dosimetry of an 192Ir high dose-rate brachytherapy source.
    Karaiskos P; Angelopoulos A; Sakelliou L; Sandilos P; Antypas C; Vlachos L; Koutsouveli E
    Med Phys; 1998 Oct; 25(10):1975-84. PubMed ID: 9800706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using LiF:Mg,Cu,P TLDs to estimate the absorbed dose to water in liquid water around an 192Ir brachytherapy source.
    Lucas PA; Aubineau-Lanièce I; Lourenço V; Vermesse D; Cutarella D
    Med Phys; 2014 Jan; 41(1):011711. PubMed ID: 24387503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
    Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
    Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental and theoretical determination of dosimetric characteristics of IsoAid ADVANTAGE 125I brachytherapy source.
    Meigooni AS; Hayes JL; Zhang H; Sowards K
    Med Phys; 2002 Sep; 29(9):2152-8. PubMed ID: 12349937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empirical dosimetric characterization of model I125-SL 125iodine brachytherapy source in phantom.
    Wallace RE
    Med Phys; 2000 Dec; 27(12):2796-802. PubMed ID: 11190963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anisotropy functions for 103Pd, 125I, and 192Ir interstitial brachytherapy sources.
    Nath R; Meigooni AS; Muench P; Melillo A
    Med Phys; 1993; 20(5):1465-73. PubMed ID: 8289730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monte Carlo dosimetry of a new 192Ir pulsed dose rate brachytherapy source.
    Karaiskos P; Angelopoulos A; Pantelis E; Papagiannis P; Sakelliou L; Kouwenhoven E; Baltas D
    Med Phys; 2003 Jan; 30(1):9-16. PubMed ID: 12557972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monte Carlo dosimetry of a new 192Ir high dose rate brachytherapy source.
    Angelopoulos A; Baras P; Sakelliou L; Karaiskos P; Sandilos P
    Med Phys; 2000 Nov; 27(11):2521-7. PubMed ID: 11128304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental determination of dosimetric characteristics of Best 125I brachytherapy source.
    Meigooni AS; Gearheart DM; Sowards K
    Med Phys; 2000 Sep; 27(9):2168-73. PubMed ID: 11011747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental determination of the Task Group-43 dosimetric parameters of the new I25.S17plus (125)I brachytherapy source.
    Moutsatsos A; Pantelis E; Papagiannis P; Baltas D
    Brachytherapy; 2014; 13(6):618-26. PubMed ID: 25108795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric characterization of a 131Cs brachytherapy source by thermoluminescence dosimetry in liquid water.
    Tailor R; Ibbott G; Lampe S; Warren WB; Tolani N
    Med Phys; 2008 Dec; 35(12):5861-8. PubMed ID: 19175142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism.
    Ballester F; Carlsson Tedgren Å; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith RL; Thomson RM; Verhaegen F; Vijande J; Ma Y; Beaulieu L
    Med Phys; 2015 Jun; 42(6):3048-61. PubMed ID: 26127057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-dimensional dosimetry in the near field of the model 200 103Pd source for interstitial brachytherapy implants using a thermoluminescent sheet.
    Iwata K; Yue NJ; Nath R
    Phys Med Biol; 2004 Sep; 49(17):4049-63. PubMed ID: 15470922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric characteristics of the InterSource103 palladium brachytherapy source.
    Meigooni AS; Sowards K; Soldano M
    Med Phys; 2000 May; 27(5):1093-100. PubMed ID: 10841414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monte Carlo dosimetric study of best industries and Alpha Omega Ir-192 brachytherapy seeds.
    Ballester F; Granero D; Pérez-Calatayud J; Casal E; Puchades V
    Med Phys; 2004 Dec; 31(12):3298-305. PubMed ID: 15651612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose distribution for endovascular brachytherapy using Ir-192 sources: comparison of Monte Carlo calculations with radiochromic film measurements.
    Sureka CS; Sunny CS; Subbaiah KV; Aruna P; Ganesan S
    Phys Med Biol; 2007 Jan; 52(2):525-37. PubMed ID: 17202631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dosimetric study on the Ir-192 high dose rate flexisource.
    Granero D; Pérez-Calatayud J; Casal E; Ballester F; Venselaar J
    Med Phys; 2006 Dec; 33(12):4578-82. PubMed ID: 17278809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of phantom material and dimensions on experimental 192Ir dosimetry.
    Carlsson Tedgren A; Carlsson GA
    Med Phys; 2009 Jun; 36(6):2228-35. PubMed ID: 19610312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An experimental MOSFET approach to characterize (192)Ir HDR source anisotropy.
    Toye WC; Das KR; Todd SP; Kenny MB; Franich RD; Johnston PN
    Phys Med Biol; 2007 Sep; 52(17):5329-39. PubMed ID: 17762089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.